Genscript Biotech Corporation (FRA:G51)
Germany · Delayed Price · Currency is EUR 1.342
-0.005 (-0.33%)
At close: Jan 30, 2026
Genscript Biotech Market Cap
Genscript Biotech has a market cap or net worth of €3.03 billion as of January 30, 2026. Its market cap has increased by 20.87% in one year.
Market Cap
3.03B
Enterprise Value
2.70B
Revenue
705.13M
Ranking
n/a
PE Ratio
1.14
Stock Price
€1.34
Market Cap Chart
Since December 30, 2015, Genscript Biotech's market cap has increased from 249.76M to 3.03B, an increase of 1,112.34%. That is a compound annual growth rate of 28.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 3.03B | 1.90% |
| Dec 31, 2025 | 2.97B | 13.27% |
| Dec 31, 2024 | 2.62B | -46.27% |
| Dec 29, 2023 | 4.88B | -22.58% |
| Dec 30, 2022 | 6.31B | -22.85% |
| Dec 31, 2021 | 8.17B | 251.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lechwerke AG | 2.50B |
| Mainova AG | 2.40B |
| Tradegate AG Wertpapierhandelsbank | 2.10B |
| Gelsenwasser AG | 1.82B |
| tonies SE | 1.14B |
| Sedlmayr Grund und Immobilien AG | 939.90M |
| Berliner Effektengesellschaft AG | 879.96M |
| Maschinenfabrik Berthold Hermle AG | 835.00M |